Have your own idea? Try our Stock Screener
Australian (ASX) Healthtech Industry Analysis
UpdatedApr 15, 2026
DataAggregated Company Financials
Companies18
- 7D8.5%
- 3M-36.2%
- 1Y-32.6%
- YTDn/a
In the last week, the Healthtech industry is up 11%, with Pro Medicus up 8.2%. During this same period, the Mach7 Technologies underperformed, falling 6.3%. In the past year, the industry is down 34%. Looking forward, earnings are forecast to grow by 6.7% annually.
Industry Valuation and Performance
Has the Australian Healthtech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 15 Apr 2026 | AU$15.5b | AU$610.6m | AU$93.5m | 29.7x | 166x | 25.4x |
| Fri, 13 Mar 2026 | AU$15.6b | AU$608.9m | AU$93.9m | 29.5x | 166x | 25.6x |
| Sun, 08 Feb 2026 | AU$19.9b | AU$460.5m | AU$3.2m | 67.3x | 6261.1x | 43.2x |
| Tue, 06 Jan 2026 | AU$26.8b | AU$465.3m | AU$2.0m | 63.1x | 13632.2x | 57.6x |
| Thu, 04 Dec 2025 | AU$29.5b | AU$466.7m | AU$1.6m | 67.1x | 18862.3x | 63.1x |
| Sat, 01 Nov 2025 | AU$30.2b | AU$467.3m | AU$1.5m | 62.5x | 19663.8x | 64.5x |
| Mon, 29 Sep 2025 | AU$33.9b | AU$467.5m | AU$1.3m | 66.3x | 26093.1x | 72.5x |
| Wed, 27 Aug 2025 | AU$33.2b | AU$567.1m | -AU$27,006,824.77 | 146.9x | -1230.2x | 58.6x |
| Fri, 25 Jul 2025 | AU$34.8b | AU$525.1m | -AU$41,520,168.73 | 183.7x | -839.1x | 66.4x |
| Sun, 22 Jun 2025 | AU$30.2b | AU$526.4m | -AU$41,720,361.28 | 157.5x | -722.9x | 57.3x |
| Tue, 20 May 2025 | AU$30.3b | AU$526.7m | -AU$41,536,124.24 | 157.8x | -729.6x | 57.5x |
| Thu, 17 Apr 2025 | AU$22.5b | AU$527.8m | -AU$41,963,039.53 | 118.3x | -535.4x | 42.6x |
| Sat, 15 Mar 2025 | AU$25.7b | AU$528.1m | -AU$41,554,254.15 | 134.9x | -619.3x | 48.7x |
| Mon, 10 Feb 2025 | AU$31.0b | AU$586.1m | -AU$63,837,477.18 | 125.4x | -486.2x | 53x |
| Wed, 08 Jan 2025 | AU$28.4b | AU$586.9m | -AU$64,183,506.39 | 153.2x | -442.4x | 48.4x |
| Fri, 06 Dec 2024 | AU$29.3b | AU$584.1m | -AU$63,359,760.01 | 226.2x | -462.8x | 50.2x |
| Sun, 03 Nov 2024 | AU$21.7b | AU$582.8m | -AU$63,245,327.03 | 174x | -342.8x | 37.2x |
| Tue, 01 Oct 2024 | AU$20.0b | AU$577.6m | -AU$61,984,773.69 | 225x | -323.3x | 34.7x |
| Thu, 29 Aug 2024 | AU$16.8b | AU$562.1m | -AU$69,663,868.30 | 104.3x | -241.1x | 29.9x |
| Sat, 27 Jul 2024 | AU$15.6b | AU$536.4m | -AU$82,652,789.53 | 113.9x | -188.8x | 29.1x |
| Mon, 24 Jun 2024 | AU$16.0b | AU$533.0m | -AU$81,596,967.11 | 116.5x | -196.5x | 30.1x |
| Wed, 22 May 2024 | AU$13.4b | AU$567.8m | -AU$89,900,358.97 | 98.3x | -149.4x | 23.7x |
| Fri, 19 Apr 2024 | AU$12.3b | AU$572.4m | -AU$103,836,832.26 | 89.4x | -118.5x | 21.5x |
| Sun, 17 Mar 2024 | AU$11.9b | AU$571.6m | -AU$103,159,055.28 | 84.9x | -115.2x | 20.8x |
| Tue, 13 Feb 2024 | AU$13.3b | AU$527.2m | -AU$134,364,544.56 | 114.3x | -99x | 25.2x |
| Thu, 11 Jan 2024 | AU$11.6b | AU$527.6m | -AU$139,868,972.00 | 103x | -82.8x | 22x |
| Sat, 09 Dec 2023 | AU$11.0b | AU$527.7m | -AU$106,622,990.00 | 98.9x | -103.4x | 20.9x |
| Mon, 06 Nov 2023 | AU$10.1b | AU$525.5m | -AU$107,351,561.00 | 93.2x | -93.7x | 19.1x |
| Wed, 04 Oct 2023 | AU$10.4b | AU$528.4m | -AU$112,044,919.00 | 93.9x | -93.1x | 19.7x |
| Fri, 01 Sep 2023 | AU$9.4b | AU$537.8m | -AU$131,423,635.00 | 86.6x | -71.5x | 17.5x |
| Sun, 30 Jul 2023 | AU$9.0b | AU$501.2m | -AU$153,588,090.00 | 93.8x | -58.8x | 18x |
| Tue, 27 Jun 2023 | AU$8.5b | AU$499.9m | -AU$152,715,342.00 | 95.3x | -55.7x | 17x |
| Thu, 25 May 2023 | AU$7.9b | AU$496.2m | -AU$145,927,000.00 | 85.9x | -53.9x | 15.8x |
| Sat, 22 Apr 2023 | AU$8.1b | AU$493.5m | -AU$145,136,375.00 | 88.3x | -56x | 16.5x |
Price to Earnings Ratio
-56x
Current Industry PE
- Investors are pessimistic on the Australian Health Care Technology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 166x which is lower than its 3-year average PE of 2kx.
- The 3-year average PS ratio of 37.1x is higher than the industry's current PS ratio of 25.4x.
Past Earnings Growth
- Total earnings for the Health Care Technology industry have gone up over the last three years, and the industry is now profitable. Revenues have grown 7.5% per year.
- This means that more sales are being generated by the industry overall, and subsequently profits are increasing too.
Industry Comparison
How does Australian Healthtech compare with similar industries?
| AU Market | 2.79% | |
| Healthcare | 1.19% | |
| Healthtech | 8.47% | |
| Healthtech | 8.47% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| PME Pro Medicus | AU$137.42 | 4.0% +AU$557.9m | -32.6% | PE61.2x | |
| 4DX 4DMedical | AU$6.33 | 3.3% +AU$117.9m | 2,121.1% | PS642.1x | |
| AYA Artrya | AU$4.25 | 9.0% +AU$55.8m | 534.3% | PS23345.6x | |
| PCK PainChek | AU$0.18 | 32.1% +AU$9.4m | -47.1% | PS11.2x | |
| TRI TrivarX | AU$0.019 | 11.8% +AU$2.3m | 46.2% | PB0.9x |
